Working
Sign in using your Enterprise Post account
Login
Password
Remember me
Cancel
Forgot your password?
Feedback
We want to hear from you. Send us your feedback!
Send us an e-mail
Name:
E-Mail:
Message:
Request a callback
Name:
Phone:
Best time to call:
Click here to request a call back.
View our
Privacy Policy
.
Home
Local
Atlanta
Boston
Chicago
Dallas
Denver
Houston
Los Angeles
Miami
Minneapolis
New York
Philadelphia
Phoenix
Portland
San Diego
San Francisco
Seattle
Toronto
Washington, D.C.
Industries
Agriculture & Mining
Education
Energy
Finance
Government
Healthcare
Manufacturing
Media
Real Estate
Retail
Technology
Teleco
Travel
MarketMaps
Videos
Updated over 1 year ago
More news & views
Hemispherx granted more time to work on chronic fatigue drug
Those waiting and waiting and waiting for action on Ampligen, an experimental treatment for chronic fatigue syndrome under development by Hemispherx Biopharma since the 1970s, are going to have to wait a little longer. The Food and Drug Administration Wednesday granted the Philadelphia biotechnology company an exte...
Comment
Share
Tweet
Source:
Philadelphia Business ...
Jan 11, 2012 - 7:58 AM
Browse Related Topics:
Philadelphia
Fda
The Food An...
Hemispherx
More
Less
Hemispherx Biopharma
Ampligen
Hemispherx
Ampligen
Leave a Comment about
Hemispherx granted more time to work on chronic fatigue drug
Cancel
Be the first to leave a comment!
Related Topics
Ampligen
Ampligen
Fda
Hemispherx
Hemispherx
Hemispherx Biopharma
Philadelphia
The Food And Drug Administration
About
Privacy
©2013
The Enterprise Post, All Rights Reserved
Share
Tweet